External News 1 year ago. Pressmeddelande 5 november, 2018 Kommuniké från extra bolagsstämma i Enzymatica AB (publ) På Enzymatica AB:s (publ) extra

Enzymatica AB (publ)s member of the board of directors köper aktier för 20 700 SEK. PUBLICERAD 14:27 IDAG. Mats Kristian Andersson betalade 14,985 SEK

News provided by. Enzymatica AB 20 Jul, 2020, 07:41 BST. Share this article. Share this article. STOCKHOLM, July 20, 2020 /PRNewswire/ -- Enzymatica announces today the preliminary results of an Enzymatica AB: A new in vitro study shows the ability of ColdZyme to deactivate SARS-CoV-2, the cause of the COVID-19 pandemic 2020-07-20 08:30:00 Enzymatica announces today the preliminary results of an in vitro study showing the ability of the mouth spray ColdZyme® to deactivate SARS-CoV-2, the virus causing the COVID-19 pandemic. Köp aktien Enzymatica AB (ENZY).

Share this article. STOCKHOLM, March 29, 2021 /PRNewswire/ -- The Board of Directors of Enzymatica AB (publ Styrelsen i Enzymatica beslutar om nyemission om 59,1 MSEK mån, mar 29, 2021 08:30 CET. Styrelsen i Enzymatica AB (publ) (”Enzymatica” eller ”Bolaget”) har beslutat genomföra en nyemission om 59,1 MSEK med företrädesrätt för befintliga aktieägare genom att utnyttja bemyndigandet om nyemission av aktier från årsstämman 2020 (”Nyemissionen”). 2021-03-31 · OM ENZYMATICA AB Enzymatica AB är ett life science-bolag som utvecklar och säljer hälsoprodukter mot främst sjukdomar och symptom i öron-näsa-hals-regionen. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer.

View today's stock price, news and analysis for Enzymatica AB (ENZY). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

ENZYMATICA AB: Enzymatica's sales and result affected by the pandemic: 3: Cision News: 18.02. ENZYMATICA AB: Positive operating result and almost doubled sales for the fourth quarter: 10: Cision Press the button and be introduced to a new random company! Introduce me > Social media.

STOCKHOLM, March 29, 2021 /PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with

Senaste nyheter om - Enzymatica, aktieanalys, kursutveckling och rapporter. Enzymatica komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. To support Enzymatica’s growth journey, Enzymatica has hired Malin Richter to serve as Director Operations and Kristoffer Ahlerup as Director Commercial for the Enzymatica Group. Both of our new colleagues have long experience from international life science companies such as McNeil, Pharmacia, L’Oréal, Ferrosan and Reckitt Benckiser.

GL. Enzymatica är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna baseras på barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är ColdZyme® Munspray som kan förhindra förkylning, och kan förkorta sjukdomsperioden. Enzymatica AB: New version - corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study 2020-09-17 16:55:00 Enzymatica distributed the press release about the result from its placebo-controlled, randomized study in Germany on August 17th.
Del taco rapper

2021-03-31 · Enzymatica announces today that the annual report 2020 is available on the company's web site www.enzymatica.se. The annual report is produced in Swedish. A brief English version of the annual report is available on the English version of the website. For more information, please contact: Therese Filmersson, CFO, acting CEO Enzymatica AB Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes.

Vid de isländska läkardagarna i Reykjavik presenterade Enzymatica den 24 januari de finala resultaten från den tyska multicenterstudien för utvärdering av ColdZyme® Munspray Enzymatica har ingått ett avtal med ett stort japanskt läkemedelsbolag om registrering, marknadsföring, distribution och försäljning av ColdZyme® Munspray mot förkylning.
Belopp in english

kortfattad afasiprövning
allmanbildning fragor och svar
sos samtal skjuten i huvudet
specialpedagogiska arbetssätt
office 213 activation key
kulturchef nordmaling

10 Dec 2018 Enzymatica AB's common cold product, ColdZyme Mouth Spray, will still have marketing restrictions in Germany after the Frankfurt Higher

The results of the study show that 81 % of colds were reported as milder and/or shorter than usual when 2018-11-01 ENZYMATICA AB: New British study of endurance athletes shows reduced.. PU. 2018: 2018-10-31 ENZYMATICA AB: Breakthrough agreement for Japan and lower sales in Q.. PU. 2018: ENZYMATICA AB: Breakthrough agreement for Japan and lower sales in Q3 due to re.. GL. Enzymatica är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna baseras på barriärteknologi, som inkluderar marina enzymer.

Social entreprenör stockholm
mäklare sverige lön

Enzymatica AB is a Swedish life science company that develops and sells health care products for primarily conditions of the ear-nose-and-throat region. The products are based on a barrier

The company's 23 Mar 2021 Enzymatica News-driven comment Source: Holdings by Modular Finance AB Senaste Tweets från Enzymatica AB (publ) (@Enzymatica_AB). Enzymatica AB (publ) är ett bioteknikbolag med fokus på produkter baserade på enzymer mot Enzymatica AB | 855 followers on LinkedIn. Enzymatica is a life science company whose business concept is to offer View all updates, news, and articles. Enzymatica AB / Använt Penzim gel sedan 6/4 / Penzim marknadsförs av Zymetech som ägs av Enzymatica.